OPINION article
Front. Oncol.
Sec. Cancer Epidemiology and Prevention
Iron reduction via periodic calibrated phlebotomy to target ferritin lowers cancer incidence and mortality in patients with peripheral artery disease: further insights from the FeAST trial
Provisionally accepted
- 1Tusk Enterprises LLC, 739003, Arlington, United States
- 2Mercy Hospital Oklahoma City, Oklahoma City, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Keywords: phlebotomy / methods, ferritins / blood, neoplasms / prevention & control, neoplasms /mortality, risk reduction behavior / statistics & numerical data
Received: 29 Aug 2025; Accepted: 13 Nov 2025.
Copyright: © 2025 Pisarik. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Paul Pisarik, okie_2015@yahoo.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.